Life Expectancy News and Research

RSS

Life expectancy is the expected (in the statistical sense) number of years of life remaining at a given age. It is denoted by e''x'', which means the average number of subsequent years of life for someone now aged ''x'', according to a particular mortality experience.

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Invida Group, the leading provider of healthcare brands and services to the Asia Pacific region, today announced that its contract with Swiss biotechnology company, Actelion, has been extended through 2015 to continue commercialization of Tracleer® for the treatment of pulmonary arterial hypertension (PAH) in crucial markets throughout Asia. Actelion signed with Invida initially in 2005, and has extended the contract to market the company’s lead product, Tracleer, in Thailand, Malaysia, Philippines, Vietnam, and Hong Kong

26 Mar 2010

Women continue to be main caregivers for minors, elderly, disabled and sick

The main conclusion of this research is that in spite of the noteworthy advances of recent decades, women continue to be the main caregivers for minors as well as for the elderly, disabled or the sick. In general, traditional family care is increasingly more unsustainable, chiefly because of women's incorporation into the workplace and the decrease in the number of housewives, the increase of the aging population, and the increasing age of the caregivers themselves.

26 Mar 2010

World TB Day coverage: Lesotho, Armenia, drug resistance, HIV coinfection

"To mark World [Tuberculosis] Day on Wednesday, Medecins Sans Frontieres [MSF] drew attention to Lesotho, which has the world's third-highest prevalence of HIV ... and the fourth-highest prevalence of tuberculosis," the Associated Press reports

26 Mar 2010

More awareness and earlier diagnosis of brain cancer needed

One of the UK’s largest surveys of brain cancer sufferers and carers, conducted by the Samantha Dickson Brain Tumour Trust, suggests that GPs and the general public need better guidance on spotting the key symptoms to aid earlier diagnosis and improve survival.

23 Mar 2010

Study: Four risk factors estimated to reduce life expectancy in the U.S.

A study published this week in PLoS Medicine finds that four risk factors - smoking, high blood pressure, high blood sugar and obesity - explain a substantial amount of the disparity in life expectancy amongst the "Eight Americas", which are groups of the US population that can be defined by race, and location and socioeconomic features of counties they live in.

23 Mar 2010

SRI International researchers to disclose preliminary results of NTD detecting diagnostic at 239th ACS

SRI International, an independent nonprofit research and development organization, will present preliminary results of a diagnostic to detect neglected tropical diseases (NTDs) at the 239th National Meeting & Exhibition of the American Chemical Society (ACS) being held on March 21-25 in San Francisco.

22 Mar 2010

Passage of comprehensive health care reform: PhRMA issues statement

The Pharmaceutical Research and Manufacturers of America (PhRMA) issued the following statement today on passage of comprehensive health care reform and accompanying reconciliation legislation in the U.S. House of Representatives:

22 Mar 2010

Research roundup: Insurance crisis tough on middle class; Hospitals' profit margins on private patients up

Private-Payer Profits Can Induce Negative Medicare Margins - "Hospitals' profit margins on privately insured patients have risen dramatically in recent years, while profit margins on Medicare patients have fallen," write the authors, who all work for MedPAC.

20 Mar 2010

Call for European Cystic Fibrosis healthcare gap to be closed

A healthcare gap amounting to a ‘death sentence’ for Cystic Fibrosis (CF) children born in Eastern Europe must be closed say researchers from the EuroCareCF Coordination Action for Cystic Fibrosis.

18 Mar 2010

New chemotherapeutic agents for colorectal cancer: High-cost/low-value medical care

New chemotherapy agents appear associated with improvements in survival time for patients with metastastic colorectal cancer, but at substantial cost, according to a report in the March 22 issue of Archives of Internal Medicine, one of the JAMA/Archives journals.

18 Mar 2010

Watchful waiting is viable option for many men with low risk prostate cancer

Active surveillance, also referred to as watchful waiting, is a viable option for many men with low risk prostate cancer although the concept continues to cause distress and confusion. James L. Mohler, MD, of Roswell Park Cancer Institute and chair of the NCCN Guidelines Panel for Prostate Cancer, discussed the role of active surveillance as well as other treatment options recommended in the recently updated NCCN Guidelines™ for Prostate Cancer at the NCCN 15th Annual Conference.

18 Mar 2010

New chemotherapy agents improve survival time for patients with metastatic colorectal cancer

New chemotherapy agents appear associated with improvements in survival time for patients with metastatic colorectal cancer but at substantial cost.

17 Mar 2010

Anti-obesity drugs fail to tackle wider issues of obesity

Scientists at the University of Liverpool argue that anti-obesity drugs fail to provide lasting benefits for health and wellbeing because they tackle the biological consequences of obesity, and not the important psychological causes of overconsumption and weight gain.

17 Mar 2010

Genentech submits ACTEMRA sBLA to FDA

Genentech, Inc., a wholly-owned member of the Roche Group, today announced that the company submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for ACTEMRA® (tocilizumab) for the prevention of structural joint damage (as assessed by radiograph) and improvement in physical function in adults with moderately to severely active rheumatoid arthritis (RA).

17 Mar 2010

Despite accomplishments and improvements, cancer remains too common disease in the U.S.

Although there have been achievements in the battle against cancer, including a decrease in the rate of death and new diagnoses, cancer remains one of the leading causes of death in the U.S., with a need for continued improvement in the areas of prevention, detection and treatment, according to a commentary in the March 17 issue of JAMA, a theme issue on cancer.

17 Mar 2010

Vertex Pharmaceuticals' telaprevir and VX-222 HCV inhibitor abstracts accepted for presentation at 45th EASL meeting

Vertex Pharmaceuticals Incorporated today announced that multiple abstracts related to the hepatitis C virus (HCV) protease inhibitor telaprevir and the HCV polymerase inhibitor VX-222 were accepted for presentation at the 45th Annual Meeting of the European Association for the Study of the Liver (EASL) in Vienna, Austria, April 14-18, 2010.

17 Mar 2010

Healthways, Blue Zones establish Healthways-Blue Zones Vitality Quest to improve community well-being

Today, Healthways, Inc. and Blue Zones, LLC, announced the establishment of Healthways-Blue Zones Vitality QuestSM, an exclusive, strategic relationship to create, support and sustain a national movement to improve community health and well-being, initially for cities in the U.S.

15 Mar 2010

Cancer care system in Canada does not meet the needs of young cancer patients

Canada's cancer care system is not meeting the unique needs of young cancer patients. Adolescent and young adult (AYA) cancer patients and survivors often 'fall through the cracks' of a system that focuses on cancer in children or adults, but does not provide specialized care for this in-between group. To understand why and develop solutions, an international group of young survivors and cancer specialists will come together in Toronto.

15 Mar 2010

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

NeuroSearch today announced that further analysis of the data from the MermaiHD study with Huntexil(R) (pridopidine) for the treatment of Huntington's disease supports potential disease modifying properties of the drug.

11 Mar 2010

Safe, adequate food and nutrition services for older adults receiving health care at home and in communities

The Society for Nutrition Education (SNE) has partnered with the American Dietetic Association (ADA) and American Society for Nutrition (ASN) to publish a position paper, "Position of the American Dietetic Association, American Society for Nutrition, and Society for Nutrition Education: Food and Nutrition Programs for Community-Residing Older Adults," focusing on access to safe and adequate food and nutrition services, including nutrition education, for the increasing number of older adults who receive health care in their homes or communities rather than in nursing homes or other residential facilities.

9 Mar 2010

Life Expectancy News and Research

Further Reading

Invida to continue commercialization of Actelion's Tracleer for PAH in crucial Asian markets

Women continue to be main caregivers for minors, elderly, disabled and sick

World TB Day coverage: Lesotho, Armenia, drug resistance, HIV coinfection

More awareness and earlier diagnosis of brain cancer needed

Study: Four risk factors estimated to reduce life expectancy in the U.S.

SRI International researchers to disclose preliminary results of NTD detecting diagnostic at 239th ACS

Passage of comprehensive health care reform: PhRMA issues statement

Research roundup: Insurance crisis tough on middle class; Hospitals' profit margins on private patients up

Call for European Cystic Fibrosis healthcare gap to be closed

New chemotherapeutic agents for colorectal cancer: High-cost/low-value medical care

Watchful waiting is viable option for many men with low risk prostate cancer

New chemotherapy agents improve survival time for patients with metastatic colorectal cancer

Anti-obesity drugs fail to tackle wider issues of obesity

Genentech submits ACTEMRA sBLA to FDA

Despite accomplishments and improvements, cancer remains too common disease in the U.S.

Vertex Pharmaceuticals' telaprevir and VX-222 HCV inhibitor abstracts accepted for presentation at 45th EASL meeting

Healthways, Blue Zones establish Healthways-Blue Zones Vitality Quest to improve community well-being

Cancer care system in Canada does not meet the needs of young cancer patients

NeuroSearch's MermaiHD study supports potential Huntington's disease modifying properties of Huntexil

Safe, adequate food and nutrition services for older adults receiving health care at home and in communities

Sensing a Healthier Future

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Latest News